Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)
REACTOME PATHWAYThe Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) pathway (Reactome ID: R-HSA-5656364) involves 1 genes and is affected by 3 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | phlorhizin | — | 224 |
| 2 | Canagliflozin | — | 295 |
| 3 | empagliflozin | — | 996 |
About the Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) Pathway
The Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) pathway is catalogued in Reactome (ID: R-HSA-5656364) and involves 1 genes. In the BiohacksAI corpus, 3 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include SLC5A1.